Search
for
Sort by
Research 751–780 of 1000+
- Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
- A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
- Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Cepharanthine, a regulator of keap1-Nrf2, inhibits gastric cancer growth through oxidative stress and energy metabolism pathway
- Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs
- Hair keratin KRT81 is expressed in normal and breast cancer cells and contributes to their invasiveness
- Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
- Androgen receptor: A promising therapeutic target in breast cancer
- Prevention and treatment of adverse effects related to chemotherapy for recurrent ovarian cancer
- Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior
- Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography
- Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
- Shaping epithelial tissues by stem cell mechanics in development and cancer
- Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models
- The symptom experiences of Puerto Rican children undergoing cancer treatments and alleviation practices as reported by their mothers
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- Matrix-Degrading Type II Transmembrane Serine Protease Matriptase: Its Role in Cancer Development and Malignancy
- Multi-functional engineered polypeptide-based drug delivery systems for improved cancer therapy
- Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing?
- Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
- Fully Natural Lecithin Encapsulated Nano-Resveratrol for Anti-Cancer Therapy
- Molecular changes in skin predict predisposition to breast cancer